About Shycocan
Shycocan is a Healthcare company based in Bengaluru (India) founded in 2020. Virus attenuation devices are developed for indoor coronavirus neutralization. Shycocan has raised $2.47 million across 2 funding rounds from investors including Exxora Trading and Exxora Trading. The company has 72 employees. Shycocan was last valued at $15.01 million in March 2023. Its Indian entity Scalene Livprotec Private Limited reported revenue of ₹9.60 Cr. Shycocan offers products and services including Shycocan Device. Its focus areas include Life Sciences, Infectious Diseases, Medical Devices and Decontamination Solutions.
Company details
Shycocan was founded in 2020 in Bengaluru, India, focusing on health technology. A device is produced that emits photons to create a negatively charged electron cloud, which neutralizes the positive charge on the S-protein of coronaviruses. This technology is applied in various indoor environments to attenuate viral activity. Operations center on device development and deployment for public health applications.
- Headquarters Bengaluru, India
- Employees 72
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Website shycocancorp.com
- Social LinkedIn X Facebook YouTube
- Legal Name Shycocare Technologies Private Limited
- Date of Incorporation 29 Jul, 2020
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹9.60 Cr
FY 2025 · +59% YoY
- Net Loss-₹41.25 Cr
FY 2025 · -430% margin
- EBITDA-₹23.85 Cr
FY 2025 · -248% margin
- Total Equity Funding$2.47M (USD)
in 2 rounds
- Latest Funding Round$1.12M (USD), Seed
Mar 2023
- Employee Count72
Associated legal entities of Shycocan
Shycocan operates through Scalene Livprotec Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Scalene Livprotec Private Limited CIN U35105KA2020PTC136616 | Active | 29 Jul 2020 | Bangalore, Karnataka | ₹9.6 Cr | 72 | 3 | View details |
Products & Services of Shycocan
Shycocan offers a comprehensive portfolio of products and services, including Shycocan Device.
Neutralizes airborne viruses and bacteria for safer indoor air environments.
Apps and channels of Shycocan
its YouTube channel ShycocanCorp has 531 subscribers and 30 videos.
Videos from Shycocan
The most watched videos on Shycocan's YouTube channel, ShycocanCorp (531 subscribers). Click a video to play it here.
More on ShycocanCorp.
Funding Insights of Shycocan
Shycocan has successfully raised a total of $2.47M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.12 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.47M
- Total Rounds 2
- Last Round Seed — $1.12M
- First Round $1.35M
(Aug 2021)
- Investors Count 2
All 2 funding rounds of Shycocan with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2023 | $1.12M | Seed | $15.01M | Exxora Trading, Exxora Trading | – |
| Aug 2021 | $1.35M | Seed | $6.8M | Exxora Trading, Exxora Trading | – |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2023 | $15.01M | •••••••• |
| Aug 2021 | $6.8M | •••••••• |
Last known valuation $15.01M (Mar 2023). 2 investors in total: 2 institutional.
Investors in Shycocan
Shycocan has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Exxora Trading and Exxora Trading.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on multiple sectors | Panaji, India | |||
Venture capital fund focused on multiple sectors |
Investor details for Shycocan
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Scalene Livprotec Private Limited (Shycocan)
Scalene Livprotec Private Limited is the primary company behind Shycocan. The board of Scalene Livprotec Private Limited currently have 3 directors; the longest-serving is Rahul Sharma, appointed in 2020. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rahul Sharma DIN 01429384 | Director | 29 Jul 2020 | 6 yrs 3 mo | Scalene Livprotec Private Limited |
| Alok Sharma DIN 02758429 | Director | 29 Jul 2020 | 6 yrs 3 mo | Scalene Livprotec Private Limited |
| Sriram Natarajan DIN 00013843 | Director | 22 Jan 2022 | 4 yrs 9 mo | Scalene Livprotec Private Limited |
Financials of Shycocan
Figures of Scalene Livprotec Private Limited, the primary company behind Shycocan, for FY 2025. Revenue was ₹9.60 Cr (+59% year on year). Net loss was -₹41.25 Cr (-430% margin). EBITDA was -₹23.85 Cr (-248% margin). Revenue has grown at a compounded annual rate of -30% over three years.
- ₹9.60 CrRevenue · FY 2025 · +59% YoY
- -₹41.25 CrNet loss · -430% margin
- -₹23.85 CrEBITDA · -248% margin
- ₹10.6 LakhPaid-up capital
- 72Employees (provident fund records)
- -30%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Scalene Livprotec Private Limited are on its company page.
Detailed financial statements for Shycocan
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Shycocan
4 dated milestones of Shycocan across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Shycocan is founded.
- Funding First funding round of $1.3M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $1.1M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Shycocan
Complete news archive for Shycocan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shycocan
Shycocan was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Shycocan is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Shycocan is a funded company, having raised a total of $2.47M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.35M, raised on Aug 2021.
Shycocan has 72 employees.
The primary company behind Shycocan, Scalene Livprotec Private Limited, reported revenue of ₹9.60 Cr for FY 2025, up 59% year on year.
Shycocan was founded in 2020 in Bengaluru, India, focusing on health technology. A device is produced that emits photons to create a negatively charged electron cloud, which neutralizes the positive charge on the S-protein of coronaviruses. This technology is applied in various indoor environments to attenuate viral activity. Operations center on device development and deployment for public health applications.
Shycocan offers Shycocan Device.
Shycocan has 2 investors. Key investors include Exxora Trading, and Exxora Trading.
The valuation of Shycocan is $15.01M as of Mar 2023.
Shycocan operates through Scalene Livprotec Private Limited.
The legal entities of Shycocan currently have 3 directors, including Sriram Natarajan, Rahul Sharma, Alok Sharma.